News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
833,656 Results
Type
Article (85714)
Company Profile (747)
Press Release (747195)
Section
Business (232298)
Career Advice (4110)
Deals (39654)
Drug Delivery (121)
Drug Development (90714)
Employer Resources (194)
FDA (17989)
Job Trends (17275)
News (395689)
Policy (39635)
Tag
Academia (2975)
Alliances (56535)
Alzheimer's disease (1360)
Approvals (17902)
Artificial intelligence (177)
Bankruptcy (394)
Best Places to Work (12558)
Biotechnology (512)
Breast cancer (198)
Cancer (1426)
Cardiovascular disease (122)
Career advice (3516)
Cell therapy (310)
Clinical research (71907)
Collaboration (488)
Compensation (259)
COVID-19 (2813)
C-suite (120)
Data (1401)
Diabetes (181)
Diagnostics (6711)
Earnings (94809)
Employer resources (167)
Events (127295)
Executive appointments (385)
FDA (18660)
Funding (440)
Gene therapy (221)
GLP-1 (712)
Government (5054)
Healthcare (20735)
Infectious disease (2912)
Inflammatory bowel disease (125)
Interviews (808)
IPO (17625)
Job creations (5180)
Job search strategy (2856)
Layoffs (493)
Legal (10050)
Lung cancer (207)
Manufacturing (225)
Medical device (14447)
Medtech (14452)
Mergers & acquisitions (22139)
Metabolic disorders (507)
Neuroscience (1708)
NextGen Class of 2024 (7658)
Non-profit (5067)
Northern California (1687)
Obesity (291)
Opinion (246)
Patents (124)
People (64324)
Pharmaceutical (152)
Phase I (22152)
Phase II (31220)
Phase III (23543)
Pipeline (520)
Postmarket research (3548)
Preclinical (10009)
Radiopharmaceuticals (259)
Rare diseases (284)
Real estate (7373)
Regulatory (26082)
Research institute (2642)
Resumes & cover letters (649)
Southern California (1473)
Startups (4276)
United States (15980)
Vaccines (667)
Weight loss (229)
Date
Today (43)
Last 7 days (677)
Last 30 days (2599)
Last 365 days (38185)
2024 (37322)
2023 (42568)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (230)
Asia (49470)
Australia (8715)
California (3913)
Canada (1436)
China (311)
Colorado (179)
Connecticut (194)
Europe (113296)
Florida (531)
Georgia (141)
Illinois (453)
Indiana (238)
Maryland (673)
Massachusetts (3152)
Michigan (191)
Minnesota (312)
New Jersey (1120)
New York (1094)
North Carolina (876)
Northern California (1687)
Ohio (154)
Pennsylvania (934)
South America (1647)
Southern California (1473)
Texas (578)
Utah (112)
Washington State (433)
There are 833,656 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
AbbVie Continues Deal-Making Spree With $200M Nimble Buy
The Nimble acquisition, which follows the $1.4 billion buy of Aliada Therapeutics in October, will help AbbVie rebuild and cement its long-term growth prospects following the Phase II failure of emraclidine in schizophrenia and in anticipation of market erosion for Skyrizi and Rinvoq, according to Guggenheim Partners analysts.
December 16, 2024
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Novo Holdings Gets FTC’s Go-Ahead for Contentious $16.5B Catalent Merger
Now that they’ve received the go-signal from both U.S. and EU anti-trust regulators, Novo Holdings and Catalent expect to wrap up their deal in the coming days.
December 16, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*
December 16, 2024
·
4 min read
Press Releases
Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development
December 16, 2024
·
2 min read
Press Releases
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
December 16, 2024
·
2 min read
Press Releases
Bavarian Nordic Enters License and Manufacturing Agreement for its Mpox Vaccine with Serum Institute of India
December 16, 2024
·
3 min read
Press Releases
Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark
December 16, 2024
·
2 min read
Press Releases
Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial
December 16, 2024
·
6 min read
Press Releases
Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing of up to €348 million
December 16, 2024
·
31 min read
Press Releases
ViroCell Biologics Expands U.S. Business Development Team With Two New Appointments
December 16, 2024
·
3 min read
1 of 83,366
Next
